COCompany announcement, tier 1 sourceMay 4, 2026
Y Combinator (YC P26)
BioStack Platforms joins Y Combinator's P26 batch.
BioStack Platforms, Inc.
Software DevelopmentBioStack provides proprietary data products and reinforcement learning environments for healthcare and drug discovery.
getbiostack.com/ ↗RVII ALLOCATION n/d · AS OF JUN 30, 2026
Facts
- CEOReported
- EFFECTIVE AUG 8, 2026
- EmployeesReported
- EFFECTIVE AUG 8, 2026
- Total fundingReported
- NO EFFECTIVE DATE STATED
Allocation history
No allocation disclosed
This holding has no reported allocation yet. It will appear here once a filing discloses one.
Events
MATERIALOTHDatabase, tier 2 sourceMar 1, 2026
Seed Round
Seed Round raised $125,000 from 1 investor.
$125KSeed
COCompany announcement, tier 1 sourceMar 1, 2026
Y Combinator Spring 2026 Batch
BioStack Platforms participated in the Y Combinator Spring 2026 accelerator batch.
MATERIALCOCompany announcement, tier 1 sourceJan 1, 2026
Y Combinator Spring 2026
Participated in Y Combinator Spring 2026 batch
MATERIALCOCompany announcement, tier 1 sourceJan 1, 2025
BioStack Platforms founded
Company founded in 2025